Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Biollaz

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
The Annals of Thoracic Surgery|August 1, 1989
Prevention of arrhythmias by flecainide after noncardiac thoracic surgeryA Borgeat, J Biollaz, M Bayer-Berger, et al.
British Journal of Clinical Pharmacology|October 1, 1989
Atrial natriuretic peptide and urinary prostaglandins in manD Benzoni, J Geoffroy, B Waeber, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
Influence of debrisoquin phenotype on the inducibility of propranolol metabolismO Shaheen, J Biollaz, R P Koshakji, et al.
European Journal of Pharmacology|October 15, 1979
The renal effects of clonidine in unanesthetized ratsJ Biollaz, F Roch-Ramel, E J Kirchertz, et al.
Schweizerische Medizinische Wochenschrift|April 25, 1992
[Value of simultaneous determination of cyclosporin blood levels using specific and nonspecific methods in liver transplantation]V Piguet, F Mosimann, A Genton, et al.
Journal of Clinical Pharmacology|November 15, 2003
Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patientsC Robatel, L A Decosterd, J Biollaz, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 14, 2002
Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LCC Robatel, T Buclin, P Eckert, et al.
Fertility and Sterility|February 1, 2002
Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilizationMarc Germond, Paola Capelli, Giuliana Bruno, et al.
Lancet (London, England)|September 12, 1981
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421"H Gavras, J Biollaz, B Waeber, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
The Annals of Thoracic Surgery|August 1, 1989
Prevention of arrhythmias by flecainide after noncardiac thoracic surgeryA Borgeat, J Biollaz, M Bayer-Berger, et al.
British Journal of Clinical Pharmacology|October 1, 1989
Atrial natriuretic peptide and urinary prostaglandins in manD Benzoni, J Geoffroy, B Waeber, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
Influence of debrisoquin phenotype on the inducibility of propranolol metabolismO Shaheen, J Biollaz, R P Koshakji, et al.
European Journal of Pharmacology|October 15, 1979
The renal effects of clonidine in unanesthetized ratsJ Biollaz, F Roch-Ramel, E J Kirchertz, et al.
Schweizerische Medizinische Wochenschrift|April 25, 1992
[Value of simultaneous determination of cyclosporin blood levels using specific and nonspecific methods in liver transplantation]V Piguet, F Mosimann, A Genton, et al.
Journal of Clinical Pharmacology|November 15, 2003
Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patientsC Robatel, L A Decosterd, J Biollaz, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 14, 2002
Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LCC Robatel, T Buclin, P Eckert, et al.
Fertility and Sterility|February 1, 2002
Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilizationMarc Germond, Paola Capelli, Giuliana Bruno, et al.
Lancet (London, England)|September 12, 1981
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421"H Gavras, J Biollaz, B Waeber, et al.
Pageof 16